focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in BRJ China Credit Fund Limited

9 Apr 2014 07:00

RNS Number : 3719E
Adamas Finance Asia Limited
09 April 2014
 



Adamas Finance Asia Limited

Investment in BRJ China Credit Fund Limited

Adamas Finance Asia Limited ("AFA" or the "Company" - AIM ticker: ADAM) has agreed to invest US$500,000 into an investment fund launched by Adamas Asset Management (HK) Limited ("Adamas"), the Hong Kong-based investment management firm that since February 2014 has been acting as AFA's investment manager.

 

The investment follows the distribution last month to AFA of a US$75,300 dividend from a US$1 million investment made during August 2013 into the Greater China Credit Fund, an investment vehicle managed by Adamas. That distribution was the first dividend received by AFA, which until a reverse takeover in February 2014 was known as China Private Equity Investment Holdings Limited.

 

The BRJ China Private Credit Fund Limited ("BRJ") was launched in August 2013 and plans to invest US$50 million, seeking target returns of 24%-30% per annum through asset-backed investments into operationally-strong growth companies in China. It is intended that BRJ will target to distribute an annual dividend of 8%, payable semi-annually. AFA has agreed to subscribe for 500 Class A US$1,000 shares in BRJ.

 

BRJ was established to provide capital for operationally-sound Chinese SME's in need of short-term bridging finance not easily available within the PRC, where more than 90% of such companies have difficulty in obtaining bank funding. BRJ aims predominantly to use property as collateral on structured loans of between RMB 10 million and RMB 15 million (US$1.7 - 2.5 million).

 

BRJ's authorised share capital is US$50,000 which is made up of 100 Management Shares and 499,900 Participating Shares. Investors are being invited to subscribe for Class A Participating Shares and Class B Participating Shares at a fixed price of US $1,000 per Class A Share and Offshore RMB 1,000 (approx. US$166) per Class B Share.

 

The launch of BRJ follows successes achieved by Adamas with both its Greater China Credit Fund and another fund, the Asia Private Credit Fund ("APCF") launched in March 2010. Exits to date from short-term structured investments made by those funds have yielded gross IRRs ranging between 27% and 34%.

 

AFA Chairman John Croft said: "This decision to invest in BRJ underscores our commitment to building a refreshed portfolio of income-generating assets attractive to investors who are seeking a high-yield investment opportunities focused on Greater China. Following our recent restructuring as Adamas Finance Asia Limited, we are now positioned to benefit from the investment advice provided by the Adamas team in Asia, which has a strong and proven track record of identifying and managing investments into high-growth businesses."

 

 

Enquiries:

 

Adamas Finance Asia Limited

John Croft

 

+44 (0) 1825 830587

Nominated Adviser

W H Ireland Limited

Tim Feather

 

+44 (0) 113 394 6611

Broker

Laurel Capital Kingsway LLP

Suni Goonetillake

 

+44 (0) 203 330 0928

Public Relations Advisers

First City Public Relations (Hong Kong)

Allan Piper

 

+852 2854 2666

Tavistock Communications (London)

Simon Hudson

 

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQKFDBABKDQQK
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.